A Controlled Trial of Cyclophosphamide in Rheumatoid Arthritis
- 22 October 1970
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 283 (17), 883-889
- https://doi.org/10.1056/nejm197010222831701
Abstract
Cyclophosphamide was given for 32 weeks to 48 patients with severe active rheumatoid arthritis. Twenty received a high dose (up to 150 mg daily), and 28 a low dose (up to 15 mg daily).Keywords
This publication has 13 references indexed in Scilit:
- Long‐term cyclophosphamide therapy in rheumatoid arthritisArthritis & Rheumatism, 1968
- The estimation of inflammatory activity in rheumatoid arthritis. Role of composite indicesArthritis & Rheumatism, 1967
- Zur hämorrhagischen Cystitis unter der Chemotherapie mit N-Lost-PhosphamidesternKlinische Wochenschrift, 1966
- A Seven‐Day variability study of 499 patients with peripheral rheumatoid arthritisArthritis & Rheumatism, 1965
- Gold Therapy in Rheumatoid Arthritis: Report of a Multi-Centre Controlled TrialAnnals Of The Rheumatic Diseases, 1960
- 1958 Revision of diagnostic criteria for rheumatoid arthritisArthritis & Rheumatism, 1959
- Empire Rheumatism Council : Multi-Centre Controlled Trial of Cortisone Acetate and Acetyl Salicylic Acid in the Long-Term Treatment of Rheumatoid Arthritis Results of Three Years' TreatmentAnnals Of The Rheumatic Diseases, 1957
- The Use of Ranks in a Test of Significance for Comparing Two TreatmentsBiometrics, 1952
- TREATMENT OF RHEUMATOID ARTHRITIS WITH NITROGEN MUSTARDJAMA, 1951
- A Modification of the Hemagglutination Test for Rheumatoid Arthritis.Experimental Biology and Medicine, 1949